The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B—a prerequisite for clinical development-Reference-Cited by-同舟云学术

The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B—a prerequisite for clinical development

Published:2012-01 Issue:2 Volume:30 Page:225-230
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Huijbers Elisabeth J.M.,Femel Julia,Andersson Karl,Björkelund Hanna,Hellman Lars,Olsson Anna-Karin

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference22 articles.

1. Generation of therapeutic antibody responses against IgE through vaccination;Vernersson;FASEB J,2002

2. Control of allergic reactions in mice by an active anti-murine IL-4 immunization;Le Buanec;Vaccine,2007

3. Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice;Ma;Am J Respir Crit Care Med,2007

4. Vaccination against the extra domain-B of fibronectin as a novel tumor therapy;Huijbers;FASEB J,2010

5. Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon;Zardi;EMBO J,1987

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG;npj Vaccines;2024-06-10

2. Evaluation of Four Adjuvant Combinations, IVAX-1, IVAX-2, CpG-1826+Montanide ISA 720 VG and CpG-1018+Montanide ISA 720 VG, for Safety and for Their Ability to Elicit Protective Immune Responses in Mice against a Respiratory Challenge with Chlamydia muridarum;Pathogens;2023-06-22

3. Vaccination with a bacterial peptide conjugated to SARS-CoV-2 receptor-binding domain accelerates immunity and protects against COVID-19;iScience;2022-08

4. Cancer Vaccination against Extracellular Vimentin Efficiently Adjuvanted with Montanide ISA 720/CpG;Cancers;2022-05-24

5. Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden;Cancer Immunology, Immunotherapy;2022-01-11